Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Article Title: Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
PMID/MRN: 27755974
Publication Date: 2016-Oct-15
Abstract:
Individuals with Down syndrome (DS) exhibit Alzheimer's disease (AD) neuropathology and dementia early in life. Blood biomarkers of AD neuropathology would be valuable, as non-AD intellectual disabilities of DS and AD dementia overlap clinically. We hypothesized that elevations of amyloid-? (A?) peptides and phosphorylated-tau in neuronal exosomes may document preclinical AD.
AD neuropathogenic proteins A? 1-42 , P-T181-tau, and P-S396-tau were quantified by enzyme-linked immunosorbent assays in extracts of neuronal exosomes purified from blood of individuals with DS and age-matched controls.
Neuronal exosome levels of A? 1-42 , P-T181-tau, and P-S396-tau were significantly elevated in individuals with DS compared with age-matched controls at all ages beginning in childhood. No significant gender differences were observed.
These early increases in A? 1-42 , P-T181-tau, and P-S396-tau in individuals with DS may provide a basis for early intervention as targeted treatments become available.
Copyright å© 2016. Published by Elsevier Inc.